Objective: The purpose of the Senior Buyer in Trading and Supply is to manage the contract portfolio (average number of contracts: 25-30, tactical and operational) in order to meet the CAPEX Asset Integrity and Maintain Margin Portfolio and to meet new requirements in accordance with The Guidelines of Category Management Contracting – Procurement (CMCP). Senior Buyer is responsible for aggregating/leveraged third-party spending/demand and developing/implementing the sourcing strategy to maximize Shell`s purchasing power and reduce total third-party spending. Senior Buyer will ensure that the sourcing strategy is brought into line with business/functional priorities by regularly working with key business players and third parties to set annual and integrated cost reduction targets. Senior Buyer manages final expenses through close collaboration with category purchasing managers/managers, maximizes the value of operational and tactical contracts and implements the Framework Enterprise Agreement (EFA) and category contracts, works with regional commercial trading managers to optimize expenses by trading houses, ensures continuity of supply through the management of ad hoc business requirements in accordance with retail expense management principles. Main Account Skills:1. Work with different customers and stakeholders in different shell companies, functions to execute business work plans for category management, ensure the delivery of contracts on market terms and provide added value through bottom Line Impacts.2. provide essential added value to Shell`s businesses and functions by:- contracting and procurement services, as well as the development and management of local agreements under the direction of the Local Procurement Lead and the Global Category Manager, as required – the application of leading supply chain management techniques – the application of supply-value-chain analyses and local project modeling, analysis and analysis of CP`s business requirements and external market dynamics – Development and implementation of commercial contractual strategies, and implementation and commercial management of operational agreements – Execution of the group contract management process for awarded business management contracts, that all business activities are completely undermined with the business strategies of Global Category Management and Tail-Ausgaben-Principes – Managing Single Orders – Reducing/Rationalizing the Number of Contracts/Suppliers – Providing cost savings at the end that affect the end result RDS – Working on the Short and Long Model Contracts Library (MCL) TemplateAdditional:- Managing Team`s Top Contracts- Playing the role of coach for team members- As an expert on its own territory (Subject Matter Expert) federal courts demand good reasons to protect confidential transaction agreements from disclosure in federal court, Confidential transaction agreements are protected from disclosure by issuing a protection order when a good cause is reported. Phillips ex rel. Estates of Byrd v.
General Motors Corp., 307 F.3d 1206, 1212 (9th Cir. 2002) (« Phillips »). The correct reason is not defined, but it is left to the discretion of the Court. Id. to 1211. However, contrary to the Hinshaw standard, the duty to seek protection must be questionable by the party, which must demonstrate that there is « specific prejudice or harm in the absence of a protection decision. » Id. at 1210-11. Nevertheless, some district courts in California have recognized that California`s strong public policy, which favors settlements, encourages « enhanced control » in establishing confidential transaction agreements. See z.B. Big Baboon Corp.
v. Dell, Inc., 2010 WL 3955831 -4 (C.D. Cal. 2010); MedImmune, L.C. v. PDL BioPharma, Inc., 2010 WL 3636211 -2 (N.D. Cal. 2010). As a result, it is likely that California`s federal courts « will further balance the interest of one party in discovering potentially relevant information against [the other party`s] interest in protecting a negotiated transaction with the expectation of confidentiality. » MedImmune, L.C., 2010 WL 3636211 at `2.